BRPI0920706A2 - partículas inaláveis compreendendo tiotrópio - Google Patents

partículas inaláveis compreendendo tiotrópio

Info

Publication number: BRPI0920706A2
Authority: BR; Brazil
Prior art keywords: tiotropium; inhalable particles; inhalable; particles
Prior art date: 2008-10-02

Application number

BRPI0920706A

Other languages

English (en)

Inventor

Antonio Sereno Guerra

Karim Amighi

Original Assignee

Laboratórios Liconsa S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-02

Filing date

2009-10-02

Publication date

2015-12-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348057&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0920706(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-10-02 Application filed by Laboratórios Liconsa S A filed Critical Laboratórios Liconsa S A

2015-12-29 Publication of BRPI0920706A2 publication Critical patent/BRPI0920706A2/pt

2021-02-02 Publication of BRPI0920706B1 publication Critical patent/BRPI0920706B1/pt

2021-05-25 Publication of BRPI0920706B8 publication Critical patent/BRPI0920706B8/pt

Links

239000002245 particle Substances 0.000 title 1
LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title 1
229940110309 tiotropium Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Electrolytic Production Of Metals (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0920706A 2008-10-02 2009-10-02 partículas inaláveis compreendendo tiotrópio, processos de preparação das mesmas, e composição farmacêutica BRPI0920706B8 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
EP08382040A EP2172190A1 (en)	2008-10-02	2008-10-02	Inhalable particles comprising tiotropium
EP08382040.7		2008-10-02
US10411308P	2008-10-09	2008-10-09
US61/104,113		2008-10-09
PCT/EP2009/062821 WO2010037845A1 (en)	2008-10-02	2009-10-02	Inhalable particles comprising tiotropium

Publications (3)

Publication Number	Publication Date
BRPI0920706A2 true BRPI0920706A2 (pt)	2015-12-29
BRPI0920706B1 BRPI0920706B1 (pt)	2021-02-02
BRPI0920706B8 BRPI0920706B8 (pt)	2021-05-25

Family

ID=40348057

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0920706A BRPI0920706B8 (pt)	2008-10-02	2009-10-02	partículas inaláveis compreendendo tiotrópio, processos de preparação das mesmas, e composição farmacêutica

Country Status (39)

Country	Link
US (1)	US20110311618A1 (pt)
EP (2)	EP2172190A1 (pt)
JP (1)	JP5622730B2 (pt)
KR (1)	KR101639089B1 (pt)
CN (1)	CN102170861B (pt)
AR (1)	AR073528A1 (pt)
AU (1)	AU2009299801B2 (pt)
BR (1)	BRPI0920706B8 (pt)
CA (1)	CA2737399C (pt)
CL (1)	CL2011000696A1 (pt)
CO (1)	CO6361899A2 (pt)
CR (1)	CR20110227A (pt)
CY (1)	CY1121090T1 (pt)
DK (1)	DK2349204T3 (pt)
DO (1)	DOP2011000091A (pt)
EC (1)	ECSP11010925A (pt)
ES (1)	ES2675857T3 (pt)
HN (1)	HN2011000864A (pt)
HR (1)	HRP20181009T1 (pt)
HU (1)	HUE038208T2 (pt)
LT (1)	LT2349204T (pt)
MA (1)	MA34560B1 (pt)
MX (1)	MX2011003491A (pt)
MY (1)	MY159172A (pt)
NI (1)	NI201100066A (pt)
NZ (1)	NZ591923A (pt)
PE (2)	PE20142435A1 (pt)
PL (1)	PL2349204T3 (pt)
PT (1)	PT2349204T (pt)
RU (2)	RU2685236C2 (pt)
SI (1)	SI2349204T1 (pt)
SM (1)	SMT201800350T1 (pt)
SV (1)	SV2011003852A (pt)
TR (1)	TR201808269T4 (pt)
TW (1)	TWI433675B (pt)
UA (1)	UA100777C2 (pt)
UY (1)	UY32160A (pt)
WO (1)	WO2010037845A1 (pt)
ZA (1)	ZA201101735B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2552414A4 (en) *	2010-03-31	2014-05-14	Glenmark Pharmaceuticals Ltd	PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION
EP2575786B1 (en) *	2010-06-03	2017-11-15	Sima Patent ve Lisanslama Hizmetleri Ltd.Sti.	Process for dry powder formulations
WO2011154014A1 (en) *	2010-06-11	2011-12-15	Gea Process Engineering A/S	Controlled humidity drying
NZ607358A (en)	2010-08-23	2015-04-24	Takeda Gmbh	Humidified particles comprising a therapeutically active substance
WO2013109216A2 (en) *	2012-01-16	2013-07-25	Mahmut Bilgic	Preparation of dry powder formulations comprising tiotropium
US9387616B2 (en)	2012-08-03	2016-07-12	Otto Männer Innovation GmbH	Hot runner injection molding apparatus with additional controller
EP2705838A1 (en) *	2012-09-06	2014-03-12	Xspray Microparticles Ab	Tiotropium preparations
KR20150135328A (ko)	2013-04-01	2015-12-02	풀매트릭스 인코퍼레이티드	티오트로피움 건조 분말
KR101748796B1 (ko) *	2015-09-30	2017-06-19	한미약품 주식회사	활성성분의 전달량이 향상된 흡입용 캡슐제
CN109789131B (zh) *	2016-09-19	2022-08-26	墨西哥氟石股份公司	药物组合物
EP4108230A1 (en) *	2021-06-24	2022-12-28	Laboratoires SMB	New dry powder composition of tiotropium for inhalation
GR1010358B (el) *	2021-09-14	2022-12-16	Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια,	Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο
CN114191418B (zh) *	2021-12-21	2023-06-09	丽珠医药集团股份有限公司	噻托溴铵双层微球及其制备方法和噻托溴铵缓释吸入剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de)	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CN1150895C (zh) *	1998-11-13	2004-05-26	杰格研究股份公司	用于吸入给药的干粉
US20020081266A1 (en) *	1999-08-20	2002-06-27	Norton Healthcare Ltd.	Spray dried powders for pulmonary or nasal administration
AP1712A (en)	2000-10-12	2007-01-24	Boehringer Ingelheim Pharma	Novel tiotropium-containing inhalation powder
EP1591121B1 (en) *	2000-12-14	2009-06-24	Ortho-McNeil-Janssen Pharmaceuticals, Inc.	Process for preparing steroid hormone products comprising a stabilizing agent in non-crystalline form
US6485279B2 (en) *	2000-12-26	2002-11-26	Carrier Corporation	Thrust load reliever
DE10126924A1 (de) *	2001-06-01	2002-12-05	Boehringer Ingelheim Pharma	Inhalationskapseln
US7754242B2 (en) *	2002-03-20	2010-07-13	Alkermes, Inc.	Inhalable sustained therapeutic formulations
CA2478974C (en) *	2002-03-20	2014-12-16	Advanced Inhalation Research, Inc.	Inhalable sustained therapeutic formulations
DE10339197A1 (de) *	2003-08-22	2005-03-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
PT1869035E (pt) *	2005-12-19	2013-01-10	Sicor Inc	Novas formas de brometo de tiotrópio e processos para sua preparação
EP1976486A1 (en) *	2006-01-27	2008-10-08	The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin	A method of producing porous microparticles
GB0716026D0 (en) *	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
GB0801876D0 (en) *	2008-02-01	2008-03-12	Vectura Group Plc	Suspension formulations

2008
- 2008-10-02 EP EP08382040A patent/EP2172190A1/en not_active Withdrawn
2009
- 2009-09-30 AR ARP090103794A patent/AR073528A1/es not_active Application Discontinuation
- 2009-10-01 TW TW098133428A patent/TWI433675B/zh active
- 2009-10-02 ES ES09783687.8T patent/ES2675857T3/es active Active
- 2009-10-02 HU HUE09783687A patent/HUE038208T2/hu unknown
- 2009-10-02 WO PCT/EP2009/062821 patent/WO2010037845A1/en not_active Ceased
- 2009-10-02 BR BRPI0920706A patent/BRPI0920706B8/pt active IP Right Grant
- 2009-10-02 AU AU2009299801A patent/AU2009299801B2/en active Active
- 2009-10-02 MY MYPI2011001426A patent/MY159172A/en unknown
- 2009-10-02 US US13/122,134 patent/US20110311618A1/en not_active Abandoned
- 2009-10-02 KR KR1020117010097A patent/KR101639089B1/ko active Active
- 2009-10-02 DK DK09783687.8T patent/DK2349204T3/en active
- 2009-10-02 PT PT97836878T patent/PT2349204T/pt unknown
- 2009-10-02 PE PE2014002239A patent/PE20142435A1/es active IP Right Grant
- 2009-10-02 EP EP09783687.8A patent/EP2349204B1/en active Active
- 2009-10-02 RU RU2014150986A patent/RU2685236C2/ru active
- 2009-10-02 RU RU2011117256/15A patent/RU2011117256A/ru unknown
- 2009-10-02 TR TR2018/08269T patent/TR201808269T4/tr unknown
- 2009-10-02 CN CN200980138843.5A patent/CN102170861B/zh active Active
- 2009-10-02 CA CA2737399A patent/CA2737399C/en active Active
- 2009-10-02 HR HRP20181009TT patent/HRP20181009T1/hr unknown
- 2009-10-02 LT LTEP09783687.8T patent/LT2349204T/lt unknown
- 2009-10-02 SM SM20180350T patent/SMT201800350T1/it unknown
- 2009-10-02 MA MA33805A patent/MA34560B1/fr unknown
- 2009-10-02 UY UY0001032160A patent/UY32160A/es active IP Right Grant
- 2009-10-02 SI SI200931854T patent/SI2349204T1/en unknown
- 2009-10-02 MX MX2011003491A patent/MX2011003491A/es active IP Right Grant
- 2009-10-02 NZ NZ591923A patent/NZ591923A/en unknown
- 2009-10-02 UA UAA201105365A patent/UA100777C2/ru unknown
- 2009-10-02 JP JP2011529566A patent/JP5622730B2/ja active Active
- 2009-10-02 PL PL09783687T patent/PL2349204T3/pl unknown
- 2009-10-02 PE PE2011000799A patent/PE20110850A1/es not_active Application Discontinuation
2011
- 2011-03-07 ZA ZA2011/01735A patent/ZA201101735B/en unknown
- 2011-03-07 SV SV2011003852A patent/SV2011003852A/es unknown
- 2011-03-29 EC EC2011010925A patent/ECSP11010925A/es unknown
- 2011-03-30 CL CL2011000696A patent/CL2011000696A1/es unknown
- 2011-03-31 HN HN2011000864A patent/HN2011000864A/es unknown
- 2011-04-01 NI NI201100066A patent/NI201100066A/es unknown
- 2011-04-01 DO DO2011000091A patent/DOP2011000091A/es unknown
- 2011-04-29 CR CR20110227A patent/CR20110227A/es unknown
- 2011-04-29 CO CO11052660A patent/CO6361899A2/es not_active Application Discontinuation
2018
- 2018-07-04 CY CY181100703T patent/CY1121090T1/el unknown

Also Published As

Publication number	Publication date
NZ591923A (en)	2012-02-24
WO2010037845A1 (en)	2010-04-08
EP2172190A1 (en)	2010-04-07
CN102170861A (zh)	2011-08-31
BRPI0920706B1 (pt)	2021-02-02
PE20142435A1 (es)	2015-01-11
TWI433675B (zh)	2014-04-11
EP2349204A1 (en)	2011-08-03
DOP2011000091A (es)	2011-04-30
PT2349204T (pt)	2018-07-06
MX2011003491A (es)	2011-06-16
EP2349204B1 (en)	2018-04-11
MY159172A (en)	2016-12-30
RU2014150986A3 (pt)	2018-07-02
SI2349204T1 (en)	2018-08-31
RU2685236C2 (ru)	2019-04-17
AU2009299801B2 (en)	2014-02-27
KR101639089B1 (ko)	2016-07-12
ES2675857T3 (es)	2018-07-13
DK2349204T3 (en)	2018-07-16
CR20110227A (es)	2011-06-24
CA2737399A1 (en)	2010-04-08
RU2011117256A (ru)	2012-11-10
HN2011000864A (es)	2015-02-09
NI201100066A (es)	2012-01-05
TR201808269T4 (tr)	2018-07-23
UA100777C2 (ru)	2013-01-25
BRPI0920706B8 (pt)	2021-05-25
HUE038208T2 (hu)	2018-10-29
UY32160A (es)	2010-04-30
AU2009299801A1 (en)	2010-04-08
MA34560B1 (fr)	2013-10-02
LT2349204T (lt)	2018-10-10
KR20110081265A (ko)	2011-07-13
CL2011000696A1 (es)	2011-07-29
CN102170861B (zh)	2014-05-14
CA2737399C (en)	2017-02-21
JP5622730B2 (ja)	2014-11-12
HRP20181009T1 (hr)	2018-08-24
AR073528A1 (es)	2010-11-10
ZA201101735B (en)	2012-05-30
JP2012504580A (ja)	2012-02-23
SV2011003852A (es)	2011-04-12
PE20110850A1 (es)	2011-11-25
RU2014150986A (ru)	2015-06-10
ECSP11010925A (es)	2011-07-29
US20110311618A1 (en)	2011-12-22
CY1121090T1 (el)	2019-12-11
TW201018468A (en)	2010-05-16
SMT201800350T1 (it)	2018-09-13
PL2349204T3 (pl)	2018-09-28
CO6361899A2 (es)	2012-01-20

Legal Events

Date	Code	Title	Description
2018-04-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-07-16	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-07-23	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-07-28	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-12-08	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-02-02	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/10/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

Publication	Publication Date	Title
SMT201600400B (it)	2017-01-10	Inalatore
BRPI1008346A2 (pt)	2016-02-23	inalador
DK2461857T3 (da)	2019-10-28	Inhalator
BRPI0906366A2 (pt)	2015-07-07	Inalador
PL3117860T3 (pl)	2019-08-30	Inhalator
BRPI0914817A2 (pt)	2015-10-27	inalador
DK3108966T3 (da)	2020-01-02	Inhalator
BR112013013026A2 (pt)	2016-08-09	inalador
SMT201400128B (it)	2015-01-15	Inalatore
BRPI0921426A2 (pt)	2016-06-07	dispositivo inalador
DK2170280T3 (da)	2013-04-15	En inhalerbar sammensætning omfattende nikotin
ECSP12011986A (es)	2012-07-31	Nebulizador
ZA201101735B (en)	2012-05-30	Inhalable particles comprising tiotropium
EP2114498A4 (en)	2010-08-25	INHALER
NO20091729L (no)	2010-11-02	Nasal aspirator
BRPI1011813A2 (pt)	2016-03-29	"inalador"
DK3141224T3 (da)	2019-08-26	Stomipose med filterkonstruktion
EP2542285A4 (en)	2015-07-22	INHALER
BR112014002724A8 (pt)	2017-06-20	inalador de pó
DK2560739T3 (da)	2014-09-01	Lommefilterenhed
PL2398464T3 (pl)	2017-09-29	Kompozycja farmaceutyczna do inhalacji
BRPI0906779A2 (pt)	2015-07-14	Inalador
DK2033675T3 (da)	2014-09-08	Inhalationsapparat
BR112012027133A2 (pt)	2017-07-18	inalador
SMT201500005B (it)	2015-05-05	Composizione framaceutica inalabile